Intriguingly, melanomas under therapeutic stress imposed by BRAF inhibitors display lineage plasticity with transient expression of NGFR, EGFR, AXL, and an AP-1 transcriptional signature and with loss of SOX1015–17. This evidence concerns the gene JUN and melanoma.